Cryo-thermal therapy inducing MI macrophage polarization created CXCL10 and IL-6-rich pro-inflammatory environment for CD4⁺ T cell-mediated anti-tumor immunity

References

• Modiano JF, Bellgrau D, Cutter GR, et al. Inflammation, apoptosis, and necrosis induced by neoadjuvant fas ligand gene therapy improves survival of dogs with spontaneous bone cancer. Mol Ther. 2012;20:2234–2243.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Fontana A, Takeda Y, et al. Induction of antitumor immunity with fas/apo-1 ligand (cd95l)-transfected neuroblastoma neuro-2a cells. J Immunol. 1999;162:7350–7357.
   PubMed Web of Science ®Google Scholar
• Hohlbaum AM, Gregory MS, Ju ST, et al. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J Immunol. 2001;167:6217–6224.
   PubMed Web of Science ®Google Scholar
• Atsumi T, Singh R, Sabharwal L, et al. Inflammation amplifier, a new paradigm in cancer biology. Cancer Res. 2014;74:8.
   PubMed Web of Science ®Google Scholar
• Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature. 2005;436:946–952.
   PubMed Web of Science ®Google Scholar
• Thakur A, Sarkar SH, Al-Khadimi Z, et al. A Th1 cytokine–enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells. Cancer Immunol Immunother. 2012;61:497–509.
   PubMed Web of Science ®Google Scholar
• Wang D, DuBois RN. Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis. 2015;36:1085–1093.
   PubMed Web of Science ®Google Scholar
• Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8:S3.
   PubMed Web of Science ®Google Scholar
• Fisher DT, Appenheimer MM, Evans SS. The two faces of IL-6 in the tumor microenvironment. Semin Immunol. 2014;26:38–47.
   PubMed Web of Science ®Google Scholar
• Dmitrieva OS, Shilovskiy IP, Khaitov MR, et al. Interleukins 1 and 6 as main mediators of inflammation and cancer. Biochemistry (Mosc). 2016;81:80–90.
   PubMed Web of Science ®Google Scholar
• Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol. 2008;8:337.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6:a016295.
   PubMed Web of Science ®Google Scholar
• Tokunaga R, Zhang W, Naseem M, et al. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40–47.
   PubMed Web of Science ®Google Scholar
• Lunardi S, Lim SY, Muschel RJ, et al. IP-10/CXCL10 attracts regulatory T cells: implication for pancreatic cancer. Oncoimmunology. 2015;4:e1027473.
   PubMed Web of Science ®Google Scholar
• Xanthou G, Duchesnes CE, Williams TJ, et al. CCR3 functional responses are regulated by both CXCR3 and its ligands CXCL9, CXCL10 and CXCL11. Eur J Immunol. 2003;33:2241–2250.
   PubMed Web of Science ®Google Scholar
• Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol. 2007;96:41–101.
   PubMed Web of Science ®Google Scholar
• Oghumu S, Varikuti S, Terrazas C, et al. CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. Immunology. 2014;143:109–119.
   PubMed Web of Science ®Google Scholar
• Sun J, Zhang A, Xu LX. Evaluation of alternate cooling and heating for tumor treatment. Int J Heat Mass Transf. 2008;51:5478–5485.
   Web of Science ®Google Scholar
• Sun JQ, Xu CC, Wei GH, et al. Tumor treatment system with alternate cooling and heating-preliminary results in an animal model. In: Olaf Dössel, Wolfgang C. Schlegel, editors. World congress on medical physics and biomedical engineering. Vol. 25. Switzerland: Springer Nature; 2009. p. 337–340.
   Google Scholar
• Liu P, Ren X, Xu LX. Alternate cooling and heating thermal physical treatment: an effective strategy against MDSCs in 4T1 mouse mammary carcinoma. ASME. 2012;45:937–938.
   Google Scholar
• Cai Z, Song M, Zhang A, et al. Numerical simulation of a new probe for the alternate cooling and heating of a subcutaneous mouse tumor model. Numer Heat Trans A Appl. 2013;63:534–548.
   Web of Science ®Google Scholar
• Zhu J, Zhang Y, Zhang A, et al. Cryo-thermal therapy elicits potent anti-tumor immunity by inducing extracellular Hsp70-dependent MDSC differentiation. Sci Rep. 2016;6:27136.
   PubMed Web of Science ®Google Scholar
• Xue T, Ping L, Yong Z, et al. Interleukin-6 induced “acute” phenotypic microenvironment promotes th1 anti-tumor immunity in cryo-thermal therapy revealed by shotgun and parallel reaction monitoring proteomics. Theranostics. 2016;6:773–794.
   PubMed Web of Science ®Google Scholar
• Liu K, He K, Xue T, et al. The cryo-thermal therapy-induced IL-6-rich acute pro-inflammatory response promoted DCs phenotypic maturation as the prerequisite to CD4+ T cell differentiation. Int J Hyperth. 2017;34:261–272.
   PubMed Web of Science ®Google Scholar
• He K, Liu P, Xu LX. The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response. Cell Death Dis. 2017;8:e2703.
   PubMed Web of Science ®Google Scholar
• Chen C, Zhang A, Cai Z, et al. Design of microprobe for accurate thermal treatment of tumor. Cryo Letters. 2011;32:275–286.
   PubMed Web of Science ®Google Scholar
• Cai Z, Song M, Sun J, et al. Design of a new probe for tumor treatment in the alternate thermal system based on numerical simulation. Engineering in medicine and biology society, EMBC, 2011 Annual international conference of the IEEE; 2011; Boston, MA.
   Google Scholar
• Moore TC, Kumm PM, Brown DM, et al. Interferon response factor 3 is crucial to poly-I:C induced NK cell activity and control of B16 melanoma growth. Cancer Lett. 2014;346:122–128.
   PubMed Web of Science ®Google Scholar
• Barreira dSR, Laird ME, Yatim N, et al. Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy. Nat Immunol. 2015;16:850–858.
   PubMed Web of Science ®Google Scholar
• Fearon DT. Immune-suppressing cellular elements of the tumor microenvironment. Annu Rev Cancer Biol. 2017;1:241–255.
   Google Scholar
• Zhou J, Tang PC, Qin L, et al. CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses. J Exp Med. 2010;207:1951–1966.
   PubMed Web of Science ®Google Scholar
• Chomarat P, Banchereau J, Davoust J, et al. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol. 2000;1:510–514.
   PubMed Web of Science ®Google Scholar
• Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol. 2011;89:207–215.
   PubMed Web of Science ®Google Scholar
• Liu M, Guo S, Hibbert JM, et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011;22:121–130.
   PubMed Web of Science ®Google Scholar
• Lai C, Yu X, Zhuo H, et al. Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma. J Biomed Nanotechnol. 2014;10:3576–3589.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12:253–268.
   PubMed Web of Science ®Google Scholar
• Nelles ME, Moreau JM, Furlonger CL, et al. Murine splenic CD4(+) T cells, induced by innate immune cell interactions and secreted factors, develop antileukemia cytotoxicity. Cancer Immunol Res. 2014;2:1113–1124.
   PubMed Web of Science ®Google Scholar
• Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117:1175–1183.
   PubMed Web of Science ®Google Scholar
• Belardelli F, Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 2002;23:201–208.
   PubMed Web of Science ®Google Scholar
• Striz I, Brabcova E, Kolesar L, et al. Cytokine networking of innate immunity cells: a potential target of therapy. Clin Sci. 2014;126:593–612.
   PubMed Web of Science ®Google Scholar
• Dudek AM, Martin S, Garg AD, et al. Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol. 2013;4:438.
   PubMed Web of Science ®Google Scholar
• Tran Janco JM, Lamichhane P, Karyampudi L, et al. Tumor-infiltrating dendritic cells in cancer pathogenesis. J Immunol. 2015;194:2985–2991.
   PubMed Web of Science ®Google Scholar
• Hope JC, Cumberbatch M, Fielding I, et al. Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice. Immunology. 1995;86:441–447.
   PubMed Web of Science ®Google Scholar
• Schaefer E, Wu W, Mark C, et al. Intermittent hypoxia is a proinflammatory stimulus resulting in IL-6 expression and M1 macrophage polarization. Hepatol Commun. 2017;1:326.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Cantor H. CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful. Cancer Immunol Res. 2014;2:91–98.
   PubMed Web of Science ®Google Scholar
• Romagnani P, Maggi L, Mazzinghi B, et al. CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. J Allergy Clin Immunol. 2005;116:1372–1379.
   PubMed Web of Science ®Google Scholar
• Kammertoens T, Qin Z, Briesemeister D, et al. B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-α, perforin)). Int J Cancer. 2012;131:1499–1508.
   PubMed Web of Science ®Google Scholar
• Facciabene A, Motz GT, Coukos G. T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res. 2012;72:2162–2171.
   PubMed Web of Science ®Google Scholar
• Asadzadeh Z, Mohammadi H, Safarzadeh E, et al. The paradox of Th17 cell functions in tumor immunity. Cell Immunol. 2017;322:15–25.
   PubMed Web of Science ®Google Scholar
• Mojic M, Takeda K, Hayakawa Y. The dark side of IFN-gamma: its role in promoting cancer immunoevasion. Int J Mol Sci. 2017;19:89.
   PubMed Web of Science ®Google Scholar
• Pearce EL, Mullen AC, Martins GA, et al. Control of effector CD8+ T cell function by the transcription factor eomesodermin. Science. 2003;302:1041–1043.
   PubMed Web of Science ®Google Scholar
• Fujita M, Kohanbash G, Fellows-Mayle W, et al. COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res. 2011;71:2664.
   PubMed Web of Science ®Google Scholar